摘要
目的:考察柴胡滴丸的临床疗效。方法:随机化、平行对照。总病例数为226例,其中治疗组114例,治疗组每次含服柴胡滴丸15粒,同时服用空白口服液10ml,每日3次。对照组112例,对照组服用口服液10ml,同时含服空白滴丸15粒,每日3次,疗程均为3天。结果:治疗组临床治愈62例,占54％;显效27例,占23.7％;有效19例,占16.7％;无效6例,占5.3％;临床总有效率94.7％。对照组临床治愈27例,占24.1％,显效17例,占15.2％;有效37例,占33.0％;无效31例,占27.7％;临床总有效率72.3％。结论:在治疗感冒时,尤其是风热感冒重度患者,柴胡滴丸优于柴胡口服液。
Objective: To evaluate the clinical efficacy and safety of Chaihu pellet. Method: A randomized open labeled controlled mullicenter clinical trial was conducted for the treatment of 226 patients with cold . The dosage of Chaihu was 15 pellet and 10ml blank oral liquid. The dosage of Chaihu oral liquid was 10ml and IS blank pellets. The duration of treatment was 3 days in both groups. 114 patients were enrolled in Chaihu pellet group, 112 patients were enrolled in Chaihu blank liquid. Result; overall efficacy rate were 94.7% for Chaihu pellet and 72. 3% for Chaihu oral liquid group, respectively. Conclusion: The results showed that there was statistical difference between two groups ( P < 0. 05).
出处
《中国医药导刊》
2000年第3期37-39,共3页
Chinese Journal of Medicinal Guide
